Jacques Irani - Concepedia

Author

Jacques Irani

Centre Hospitalier Universitaire de Poitiers ORCID

Also Known As

Bertrand Dore, Cedric Lebacle, Didier Bon, Irani Jacques, Irani, J., J Irani, J. B. Irani, J. IRANI, J. Irani, JACQUES IRANI

294

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Poitiers Université de Poitiers Assistance Publique – Hôpitaux de Paris Bicêtre Hospital Sorbonne Université

About

Jacques Irani is an author at Centre Hospitalier Universitaire de Poitiers specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	2K
2	Public Health	4	4	97
3	Engineering	2	2	29
4	Biostatistics	2	2	128
5	Health Sciences	1	1	34

Jacques Irani

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients Paolo Gontero, Richard Sylvester, Francesca Pisano, European Urology Prognostic FactorsUrological ResearchUrologyBacillus Calmette-guérinUrologic Cancer Epidemiology	2014	241
Patient tolerance of transrectal ultrasound‐guided biopsy of the prostate Jacques Irani, F Fournier, Delphine Bon, British Journal of Urology	1997	238
Inflammation in Benign Prostatic Hyperplasia: Correlation With Prostate Specific Antigen Value Jacques Irani, P. Levillain, Jean‐Michel Goujon, The Journal of Urology	1997	190
Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions Alexandre de la Taille, Jacques Irani, Markus Graefen, The Journal of Urology	2011	150
The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin Paolo Gontero, Richard Sylvester, Francesca Pisano, British Journal of Urology	2015	150
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS” Marc‐Oliver Grimm, Antoine G. van der Heijden, Marc Colombel, European Urology Urological ResearchUrologyBcg InstillationsUrologic Cancer EpidemiologyGenitourinary Cancer	2020	122
High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy Jacques Irani, Jean‐Michel Goujon, E. Ragni, Urology UrologyGenitourinary CancerMedicineRadical ProstatectomyHigh-grade Inflammation	1999	105
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome Marco Auprich, Alexander Haese, Jochen Walz, European Urology Urinary Pca3-based NomogramsUrogenital RadiologyExternal ValidationUrologyOncology	2010	103
Prognostic Significance of Tumor Volume after Radical Prostatectomy: A Multivariate Analysis of Pathological Prognostic Factors Laurent Salomon, Olivier Levrel, Aristotelis G. Anastasiadis, European Urology UrologySurgical OncologyGenitourinary CancerMedicineSurgical Pathology	2002	100
Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population Y. Neuzillet, X. Tillou, Romain Mathiéu, European Urology Outcome Features ComparedUrologyRenal FunctionGenitourinary CancerKidney Research	2011	99

Page 1